The recently published article Lower Urinary Tract Symptoms: What’s New in Medical Treatment? in the European Urology Focus Review explores some of these new treatments. This was prepared, with co-authors, Dr. Peyronnet and Dr. Michel, to review emerging data and clinical trials on pharmacological treatments of lower urinary tract conditions. Our basic science colleagues have spent decades understanding the physiology and biology of the lower urinary tract, leading to the discovery of molecules that are potential therapeutic targets. After understanding the mechanism of action, pharmacokinetics, toxicities of these drugs, human trials help us understand the efficacy, appropriate use, and safety of these emerging treatments. It will be a good thing for our patients if the next review we write is about sequencing therapies, or choosing between different drugs, as that will signify that we have more tools available to help manage their LUTS.
Written by: Benjamin M. Brucker, MD
Lower Urinary Tract Symptoms: What’s New in Medical Treatment?
AUA 2018 Oral Presentation:
Title: Extended First Uninterrupted Sleep Period (FUSP) in Nocturia Patients Following Treatment Desmopressin Using an Emulsified Microdose Formulation
Presenter: Dr. Benjamin Brucker, Asst. Prof. of Urology and Obstetrics and Gynecology at New York University Langone Medical Center